Brian Halak
Managing Partner at Medical Excellence Capital
About
Senior life science investor who joined MEC in 2021. He spent two decades at Domain Associates since 2001, becoming partner in 2006, and invested in over a dozen companies including Tobira Therapeutics (acquired by Allergan for $1.7B). He also founded and led WindMIL Therapeutics and advised the creation of Nobias Therapeutics.
Colleagues at Medical Excellence Capital
Annabel Stoddart
Office Manager and Executive Assistant at Medical Excellence Capital
Brad Ringeisen
Scientific Advisory Board – Executive Director of Innovative Genomics Institute at Medical Excellence Capital
Douglas C Wallace
Scientific Advisory Board – Director of Center for Mitochondrial and Epigenomic Medicine at Medical Excellence Capital
Eric Heil
Managing Partner at Medical Excellence Capital
Gregg L. Semenza
Scientific Advisory Board – Professor at Johns Hopkins at Medical Excellence Capital
John P. Hornbostel
Counsel at Medical Excellence Capital
John Prufeta
Chief Executive Officer and Managing Partner at Medical Excellence Capital
Joni Mancini
Managing Partner at Medical Excellence Capital